A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver
NCT02966223
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
20
Enrollment
OTHER
Sponsor class
Stopped
Sponsor prematurely withdrew financial support.
Conditions
HCC
Liver Cancer
Interventions
RADIATION:
MRI and HIDA scan
Sponsor
Indiana University
Collaborators
[object Object]